Regarding RANKL expression, 17 out of 55 tumors (30.1%) exhibited RANKL expression in tumor cells, with 12 assigned to the experimental group and 5 to the control group (p=0.819, well balanced). This evidence concerns the gene TNFSF11 and neoplasm.